Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
Article
Google Scholar
Song Z, Wu Y, Yang J, Yang D, Fang X. Progress in the treatment of advanced gastric cancer. Tumour Biol. 2017;39:101042831771462.
Article
Google Scholar
Sugimoto M, Yamaoka Y, Furuta T. Influence of interleukin polymorphisms on development of gastric cancer and peptic ulcer. World J Gastroenterol. 2010;16:1188–200.
Article
CAS
Google Scholar
Cong AW, Sun YH, Shen ZB, Wang XF, Yin YQ, Fang Y, et al. Relationship between clinicopathologic factors and prognosis of patients with early gastric cancer. Chin J Digest Surg. 2009;8:338–40.
Pasechnikov V, Chukov S, Fedorov E, Kikuste I, Leja M. Gastric cancer: Prevention,screening and early diagnosis. World J Gastroenterol. 2014;20:13842.
Article
Google Scholar
Lizbeth RK, Augustine D, Rao RS, Sowmya SV, Patil S. Biomarkers in tumorigenesis using Cancer cell lines: a systematic review. Asian Pac J Cancer Prev. 2017;18:2329–37.
Google Scholar
Nagaraj SH, Reverter A. A Boolean-based systems biology approach to predict novel genes associated with cancer: application to colorectal cancer. BMC Syst Biol. 2011;5:35.
Article
Google Scholar
Tetsuya U, Stefano V, Hiroshi O, Masayoshi S, Cristian T, Simona R, et al. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol. 2010;11:136–46.
Article
Google Scholar
Carvalho J, van Grieken NC, Pereira PM, Sousa S, Tijssen M, Buffart TE, et al. Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer. J Pathol. 2012;228:31–44.
CAS
PubMed
Google Scholar
Dong X, Liu Y. Expression and significance of miR-24 and miR-101 in patients with advanced gastric cancer. Oncol Lett. 2018;16:5769–74.
CAS
PubMed
PubMed Central
Google Scholar
Rossi T, Tedaldi G, Petracci E, Abou Khouzam R, Ranzani GN, Morgagni P, et al. E-cadherin Downregulation and microRNAs in sporadic intestinal-type gastric Cancer. Int J Mol Sci. 2019;20:4452.
Article
Google Scholar
Imamura T, Komatsu S, Ichikawa D, Miyamae M, Okajima W, Ohashi T, et al. Low plasma levels of miR-101 are associated with tumor progression in gastric cancer. Oncotarget. 2017;8:106538–50.
Article
Google Scholar
Zhang Y, Han T, Feng D, Li J, Wu M. Peng X, et al. Carcinogenesis: Screening of non-invasive miRNA biomarker candidates for metastasis of gastric cancer by small RNA sequencing of plasma exosomes; 2019.
Google Scholar
Zoalfaghari A, Aletaha N, Roushan N, Taslimi R, Foroutan H, Faridnia B. Accuracy of pepsinogens for early diagnosis of atrophic gastritis and gastric cancer in Iranian population. Med J Islam Repub Iran. 2014;28:150.
PubMed
PubMed Central
Google Scholar
Li P, He C, Sun L, Dong N, Yuan Y. Pepsinogen I and II expressions in situ and their correlations with serum pesignogen levels in gastric cancer and its precancerous disease. BMC Clin Pathol. 2013;13:22.
Zhang XM, Li JX, Zhang GY, Li XH, Gu H. The value of serum pepsinogen levels for the diagnosis of gastric diseases in Chinese Han people in midsouth China. BMC Gastroenterol. 2014;14:3.
PubMed
PubMed Central
Google Scholar
Liu WJ, Xu Q, Sun LP, Dong QG, He CY, Yuan Y. Expression of serum let-7c, let-7i, and let-7f microRNA with its target gene, pepsinogen C, in gastric cancer and precancerous disease. Tumour Biol. 2015;36:3337–43.
Article
CAS
Google Scholar
Wu YF, Xu Q, He CY, Li Y, Liu JW, Deng N, et al. Association of Polymorphisms in three pri-miRNAs that Target Pepsinogen C with the Risk and Prognosis of Gastric Cancer. Sci Rep. 2017;7:39528.
Article
CAS
Google Scholar
Livak KJST. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2(−Delta Delta C(T))Method. Methods. 2001;25(4):402–8.
Article
CAS
Google Scholar
Walker R, Poleszczuk J, Mejia J, Lee JK, Coppola D. Toward early detection of helicobacter pylori-associated gastric cancer. Gastric Cancer. 2017;21:1–8.
Google Scholar
Tan YK, Fielding JWL. Early diagnosis of early gastric cancer. Eur J Gastroenterol Hepatol. 2006;18:821–9.
Article
Google Scholar
Wu WKK, Lee CW, Cho CH, Fan D, Wu K, Yu J, et al. MicroRNA dysregulation in gastric cancer: a new player enters the game. Oncogene. 2010;29:5761–71.
Article
CAS
Google Scholar
Nishida N, Mimori K, Fabbri M, Yokobori T, Sudo T, Tanaka F, et al. MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab. Clin Cancer Res. 2011;17:2725–33.
Article
CAS
Google Scholar
Inoue T, Iinuma H, Ogawa E, Inaba T, Fukushima R. Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer. Oncol Rep. 2012;27:1759–64.
PubMed
Google Scholar
Naito Y, Yasuno K, Tagawa H, Sakamoto N, Oue N, Yashiro M, et al. MicroRNA-145 is a potential prognostic factor of scirrhous type gastric cancer. Oncol Rep. 2014;32:1720–6.
Article
CAS
Google Scholar
Zhao J, Zhu C, Li Z. Diagnostic value of serum pepsinogen, gastrin-17 and helicobacter pylori antibody for atrophic gastritis and gastric cancer. Chin J Gastroenterol. 2016;21:376–9.
Miki K. Gastric cancer screening using the serum pepsinogen test method. Gastric Cancer. 2006;9:245–53.
Article
Google Scholar
Begum A, Baten MA, Begum Z, Ahsan MM, Rahman SF, Chowdhury F, et al. Role of serum pepsinogen I and II ratio in screening of gastric carcinoma. Mymensingh Med J. 2017;26:628.
CAS
PubMed
Google Scholar
Watabe H, Mitsushima T, Yamaji Y, Okamoto M, Wada R, Kokubo T, et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut. 2005;54:764–8.
Article
CAS
Google Scholar
Sembiring J, Sarumpaet K, Ganie RA. Diagnostic test pepsinogen I and combination with tumor marker CEA in gastric cancer. Earth & Environmental Science: Iop Conference Series; 2018.
Book
Google Scholar
Niu WW, Yang CC, Duan ZY, Huo XH, Gastroenterology DO. The diagnostic value of miRNA-92a combined with micro pepsinogen in gastric carcinoma. J Hebei Med Univ. 2017;38:638–41.
Wu G, Chen L, Zhao C, Xiao M. The value of combined detection of serum gastrin-17 and pepsinogen in the early screening of gastric cancer. Biomed Res. 2017;28:7972–6.
CAS
Google Scholar